Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | EPOR | P19235 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | PTGES | O14684 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.42 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.42 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.42 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20641024 | 1.00 | KMT2A (0.46) | KMT2AMEN1L3MBTL1MAPTEPOR | |
| SCHEMBL10315707 | 1.00 | KMT2A (0.46) | KMT2AMEN1L3MBTL1MAPTEPOR | |
| SCHEMBL9684904 | 0.87 | ALDH1A1 (0.47) | KMT2AMEN1L3MBTL1MAPTEPOR | |
| SCHEMBL9684900 | 0.87 | ALDH1A1 (0.47) | KMT2AMEN1L3MBTL1MAPTEPOR | |
| SCHEMBL10315704 | 0.85 | KMT2A (0.46) | KMT2AMEN1L3MBTL1MAPTEPOR | |
| SCHEMBL17283024 | 0.84 | KMT2A (0.49) | KMT2AMEN1L3MBTL1MAPTEPOR | |
| SCHEMBL6053231 | 0.84 | MEN1 (0.47) | KMT2AMEN1L3MBTL1NPC1RAB9A | |
| SCHEMBL17275437 | 0.83 | KMT2A (0.47) | KMT2AMEN1L3MBTL1MAPTEPOR | |
| SCHEMBL17275438 | 0.83 | KMT2A (0.47) | KMT2AMEN1L3MBTL1MAPTEPOR | |
| SCHEMBL28625441 | 0.83 | KMT2A (0.47) | KMT2AMEN1L3MBTL1MAPTEPOR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8217196-B2 | Process for producing α-fluoro-β-amino acids | CENTRAL GLASS COMPANY, LIMITED (JP) | 2012-07-10 | — | — | US | disclosed |
| US-20110015428-A1 | Process for Producing Alpha-Fluoro-Beta-Amino Acids | CENTRAL GLASS COMPANY, LIMITED (JP) | 2011-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110015428-A1 | Process for Producing Alpha-Fluoro-Beta-Amino Acids | PHF2, BCAT2, EEF2 | KMT2A 1310/4885MEN1 1200/4885L3MBTL1 1886/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.